ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that the National Comprehensive ...

This article is part of our series on clinical data considerations. Read How to Prepare for Disclosure. For publicly traded biotech companies, disclosing clinical trial data can be an exciting ...

PHILADELPHIA and VANCOUVER, British Columbia, March 18, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, ...

Healthcare providers receive data from many disparate sources: hospitals, doctors’ offices, labs and lab machines, medical devices, pharmacies, and more. Investment in the correct infrastructure to ...

This article is part of our series on clinical data considerations. Read How to Approach Fundraising and Investor Relations. When it comes to disclosing clinical trial data in the biotechnology arena, ...

Attention-deficit/hyperactivity disorder or ADHD translates in different ways across the population, unlike the ...

JOURNAVX met the primary endpoint by demonstrating statistically significant superior reduction in pain vs placebo. 1,b JOURNAVX did not meet the first key secondary endpoint that hypothesized ...

Jasper Therapeutics, Inc. announced that it is presenting updated clinical data from its Phase 1b/2a BEACON study on briquilimab, an antibody therapy targeting c-Kit to treat mast cell-driven diseases ...

Payer-provider clinical data exchange plays a critical role in payer operations, helping streamline workflows and improve patient care. Traditionally, this exchange ...

This program celebrates those who drive innovation, efficiency and excellence across the healthcare industry. By acknowledging the leading innovators within the industry, Modern Healthcare aims to ...

Despite rapid growth, only 9.2% of DCTs are multiregional and over 80% single-country, indicating challenges in international implementation. 2 With regulatory agencies 4–7 underscoring risk-based ...